Share this article
Share this article
AUBURN, Ala., Aug. 4, 2021 /PRNewswire/ SiO2 Materials Science, a U.S. advanced materials science corporation introducing breakthrough disruptive technology for containment systems for biological pharmaceuticals, vaccines, and molecular diagnostics, today announced a $64 million agreement with the federal government.
The agreement with the Department of Defense s Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) in partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, supports additional infrastructure of the company s state-of-the-art, patented, primary packaging containment system platform for storing novel biological vaccines and therapeutics including coronavirus (SARS-CoV-2).
SiO2 s Materials Science Receives $64 Million Contract From U S Gov to Support Additional Scale Up of Advanced Primary Packaging Platform for Biological Drugs and Vaccines
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
INOVIO Doses First Participant in Phase 2 Trial for its DNA Vaccine Against Middle East Respiratory Syndrome (MERS), a Coronavirus Disease
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
MSD Announces Supply Agreement with U S Government for Molnupiravir, an Investigational Oral Antiviral Candidate for Treatment of Mild to Moderate COVID-19
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.